Figure 4.

MiR‐29a‐3p expression in human laryngocarcinoma. (A) Relative miR‐29a‐3p expression levels in laryngocarcinoma tissues and their corresponding adjacent normal tissues. MiR‐29a‐3p expression was assessed by real‐time RT‐PCR. T, laryngocarcinoma tissues; N, adjacent normal tissues. (B) Average expression level of miR‐29a‐3p in cancer tissues or the normal control tissues. T, laryngocarcinoma tissues; N, adjacent normal tissues. Data assessed from three independent experiments and the P values were calculated by t‐test (*P < 0.05; **P < 0.01).